alexa The Challenge Of Improve Disease Treatment With Protein Engineering. The Contributions Of X-ray Crystallography | 72452
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

9th International Conference on Structural Biology

Stephanie Bath de Morais and Tatiana A C B Souza
FIOCRUZ, Brazil
ScientificTracks Abstracts: J Proteomics Bioinform
DOI: 10.4172/0974-276X-C1-100
Abstract
Acute Lymphoid Leukemia is the most common neoplasia in childhood. The multi-therapeutic treatment resulted in remarkable advances in treatment of children, with 90.4% survival rate. L-asparaginase has been a central component of ALL therapy for over 40 years and acts by depleting plasma asparagine. In contrast to the normal cells, tumor cells lack the ability to synthesize asparagine and thus depend on external uptake of this amino acid for growth. Nowadays, three asparaginases are used in therapy: native L-asparaginase II from Escherichia coli, a pegylated form of this enzyme and L-asparaginase isolated from Erwinia chrysanthemi. Among the commercially available L-asparaginases, the E. coli enzyme presents the highest catalytic activity but also the highest toxicity, due to its further ability to hydrolyze glutamine, generating glutamate. Moreover, the immune response in patients under therapy with bacterial asparaginases can result in enzyme neutralization and the need to proceed the treatment with one of the alternative L-asparaginases. Based on the analysis of the available crystal structures we have designed, produced and crystallized E. coli asparaginase with modifications. Crystals diffracted up to 1.65 Å resolution at the Soleil Synchrotron. We combine structural analysis with kinetic and cellular approaches to identify the determinants of E. coli asparaginase toxicity. In addition, we have been working on the production of modified human asparaginases for structural characterization, kinetic and anti-leukemic activity assays. The introduction of human asparaginase in ALL treatment would avoid the problems caused by the bacterial enzymes, however a major difficulty in the therapeutic use of human enzyme comes from the fact that human asparaginases need to undergo activation through an auto-cleavage step, which was shown to be a low efficiency process in vitro, reducing the enzyme activity. These structural analyses gather insights about how engineering asparaginases can improve ALL treatment.
Biography

Stephanie Bath de Morais performs her PhD under Tatiana Souza supervision and coordinate projects involving advances in leukemia treatment advances. She is part of the team since 2013 and has expertise in molecular, structural and cancer biology.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7